Search Prime Grants

U01CA164947

Cooperative Agreement

Overview

Grant Description
Post GWA studies in testicular germ cell tumors.
Funding Goals
NOT APPLICABLE
Place of Performance
Philadelphia, Pennsylvania 19104 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/16 to 08/31/25 and the total obligations have increased 887% from $1,188,917 to $11,729,725.
Trustees Of The University Of Pennsylvania was awarded Post genome wide association studies in testicular germ cell tumors Cooperative Agreement U01CA164947 worth $11,729,725 from National Cancer Institute in September 2012 with work to be completed primarily in Philadelphia Pennsylvania United States. The grant has a duration of 13 years and was awarded through assistance program 93.393 Cancer Cause and Prevention Research. The Cooperative Agreement was awarded through grant opportunity Research Project Grant (Parent R01 Clinical Trial Not Allowed).

Status
(Ongoing)

Last Modified 9/20/24

Period of Performance
9/21/12
Start Date
8/31/25
End Date
100.0% Complete

Funding Split
$11.7M
Federal Obligation
$0.0
Non-Federal Obligation
$11.7M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U01CA164947

Subgrant Awards

Disclosed subgrants for U01CA164947

Transaction History

Modifications to U01CA164947

Additional Detail

Award ID FAIN
U01CA164947
SAI Number
U01CA164947-2191119152
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
GM1XX56LEP58
Awardee CAGE
7G665
Performance District
PA-03
Senators
Robert Casey
John Fetterman

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $3,664,842 100%
Modified: 9/20/24